Nonalcoholic fatty liver disease: Biomarkers as diagnostic tools for liver damage assessment in adult patients from Argentina | ||
| dc.conicet.fuente | unificacion | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas | |
| dc.conicet.organizacion | Gobierno de la Ciudad de Buenos Aires. Hospital General de Niños "Ricardo Gutiérrez" | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas | |
| dc.conicet.organizacion | Gobierno de la Ciudad de Buenos Aires. Hospital General de Niños "Ricardo Gutiérrez" | |
| dc.conicet.organizacion | Hospital Italiano | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas | |
| dc.conicet.organizacion | Hospital Italiano | |
| dc.conicet.organizacion | Hospital Italiano | |
| dc.conicet.organizacion | Hospital Italiano | |
| dc.conicet.organizacion | Instituto Universidad de la Fundación "Héctor Barceló" | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas | |
| dc.conicet.organizacion | Gobierno de la Ciudad de Buenos Aires. Hospital General de Niños "Ricardo Gutiérrez" | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas | |
| dc.conicet.organizacion | Gobierno de la Ciudad de Buenos Aires. Hospital General de Niños "Ricardo Gutiérrez" | |
| dc.conicet.paisOrganizacion | Argentina | |
| dc.conicet.paisOrganizacion | Argentina | |
| dc.conicet.paisOrganizacion | Argentina | |
| dc.conicet.paisOrganizacion | Argentina | |
| dc.conicet.paisOrganizacion | Argentina | |
| dc.conicet.paisOrganizacion | Argentina | |
| dc.conicet.paisOrganizacion | Argentina | |
| dc.conicet.paisOrganizacion | Argentina | |
| dc.conicet.paisOrganizacion | Argentina | |
| dc.conicet.paisOrganizacion | Argentina | |
| dc.conicet.paisOrganizacion | Argentina | |
| dc.conicet.paisOrganizacion | Argentina | |
| dc.conicet.paisOrganizacion | Argentina | |
| dc.conicet.paisOrganizacion | Argentina | |
| dc.conicet.produccionid | 7568092 | |
| dc.contributor.author | Valva, Pamela | |
| dc.contributor.author | Rios, Daniela Alejandra | |
| dc.contributor.author | Casciato, Paola | |
| dc.contributor.author | Gadano, Adrián Carlos | |
| dc.contributor.author | Galdame, Omar | |
| dc.contributor.author | Mullen, Eduardo | |
| dc.contributor.author | Bertot, Gustavo | |
| dc.contributor.author | de Matteo, Elena Noemí | |
| dc.contributor.author | Preciado, María Victoria | |
| dc.date.accessioned | 2019-03-26T14:29:44Z | |
| dc.date.available | 2019-03-26T14:29:44Z | |
| dc.date.issued | 2017-12 | |
| dc.date.updated | 2019-03-20T13:34:55Z | |
| dc.description.abstract | Background Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease whose prevalence has been increasing constantly and linked to the global obesity epidemic. The NAFLD histologic spectrum ranges from simple steatosis to nonalcoholic steatohepatitis (NASH), which can progress to cirrhosis and hepatocellular carcinoma. Liver biopsy is the only reliable means to diagnose and stage NASH, but its invasive nature limits its use. Therefore, the prediction of hepatic injury by means of the development of new noninvasive tests represents a growing medical need. Our aim was to evaluate matrix deposition and cell-death markers, which correlate with liver injury in an NAFLD patient cohort. Patients and methods Liver biopsies and serum from 34 NAFLD adult patients were analyzed. Histological parameters were evaluated. Matrix deposition [hyaluronic acid (HA) and tissue inhibitor of matrix metalloproteinase inhibitor-1 (TIMP-1)] and cell-death markers [cytokeratin-18 (M65) and caspase-cleaved cytokeratin-18 (M30)] were measured in serum samples. Results HA showed an association with fibrosis severity (P=0.03) and M30 with steatosis (P=0.013), inflammation (P=0.004), and fibrosis severity (P=0.04). In contrast, TIMP-1 and M65 showed no association with any histological parameter of liver injury. The evaluation of diagnostic accuracy showed good performance as less invasive markers of significant fibrosis of both HA (area under the receiver operating characteristic curve: 0.928) and M30 (area under the receiver operating characteristic curve: 0.848). Conclusion Biomarkers are essential tools that may provide a quick and accurate diagnosis for patients with life-threatening NAFLD and NASH. HA and M30, together or determined sequentially, have been found to be straightforward tests that may be sufficient to predict significant fibrosis even in a primary care center of an underdeveloped country. | es |
| dc.description.fil | Fil: Valva, Pamela. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Gobierno de la Ciudad de Buenos Aires. Hospital General de Niños "Ricardo Gutiérrez"; Argentina | |
| dc.description.fil | Fil: Rios, Daniela Alejandra. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Gobierno de la Ciudad de Buenos Aires. Hospital General de Niños "Ricardo Gutiérrez"; Argentina | |
| dc.description.fil | Fil: Casciato, Paola. Hospital Italiano; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina | |
| dc.description.fil | Fil: Gadano, Adrián Carlos. Hospital Italiano; Argentina | |
| dc.description.fil | Fil: Galdame, Omar. Hospital Italiano; Argentina | |
| dc.description.fil | Fil: Mullen, Eduardo. Hospital Italiano; Argentina | |
| dc.description.fil | Fil: Bertot, Gustavo. Instituto Universidad de la Fundación "Héctor Barceló"; Argentina | |
| dc.description.fil | Fil: de Matteo, Elena Noemí. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Gobierno de la Ciudad de Buenos Aires. Hospital General de Niños "Ricardo Gutiérrez"; Argentina | |
| dc.description.fil | Fil: Preciado, María Victoria. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Gobierno de la Ciudad de Buenos Aires. Hospital General de Niños "Ricardo Gutiérrez"; Argentina | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Valva, Pamela; Rios, Daniela Alejandra; Casciato, Paola; Gadano, Adrián Carlos; Galdame, Omar; et al.; Nonalcoholic fatty liver disease: Biomarkers as diagnostic tools for liver damage assessment in adult patients from Argentina; Lippincott Williams; European Journal Of Gastroenterology & Hepatology; 30; 6; 12-2017; 637-644 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 0954-691X | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/72512 | |
| dc.journal.ciudad | Philadelphia | es |
| dc.journal.number | 6 | es |
| dc.journal.pagination | 637-644 | es |
| dc.journal.pais | Estados Unidos | es |
| dc.journal.title | European Journal Of Gastroenterology & Hepatology | es |
| dc.journal.volume | 30 | es |
| dc.language.iso | eng | es |
| dc.publisher | Lippincott Williams | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://insights.ovid.com/pubmed?pmid=29384795 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1097/MEG.0000000000001079 | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | Hyaluronic Acid | es |
| dc.subject | M30 | es |
| dc.subject | M65 | es |
| dc.subject | Nonalcoholic Fatty Liver Disease | es |
| dc.subject | Tissue Inhibitor of Matrix Metalloproteinase Inhibitor-1 | es |
| dc.subject.classification | Otras Ciencias de la Salud | es |
| dc.subject.classification | Ciencias de la Salud | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | Nonalcoholic fatty liver disease: Biomarkers as diagnostic tools for liver damage assessment in adult patients from Argentina | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.ded71d27-4077-45b9-bbd2-8d7c89bbaf22_D.pdf
- Tamaño:
- 2.03 MB
- Formato:
- Adobe Portable Document Format